UniProt ID | SL9A4_HUMAN | |
---|---|---|
UniProt AC | Q6AI14 | |
Protein Name | Sodium/hydrogen exchanger 4 | |
Gene Name | SLC9A4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 798 | |
Subcellular Localization |
Apical cell membrane Multi-pass membrane protein. Basolateral cell membrane Multi-pass membrane protein. Cytoplasmic granule membrane Multi-pass membrane protein. Found in zymogen granule membranes.. |
|
Protein Description | Involved in pH regulation to eliminate acids generated by active metabolism or to counter adverse environmental conditions. Major proton extruding system driven by the inward sodium ion chemical gradient. Plays an important role in signal transduction. May play a specialized role in the kidney in rectifying cell volume in response to extreme fluctuations of hyperosmolar-stimulated cell shrinkage. Is relatively amiloride and ethylisopropylamiloride (EIPA) insensitive. Can be activated under conditions of hyperosmolar-induced cell shrinkage in a sustained intracellular acidification-dependence manner. Activated by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) in a sustained intracellular acidification-dependence manner. Affects potassium/proton exchange as well as sodium/proton and lithium/proton exchange. In basolateral cell membrane, participates in homeostatic control of intracellular pH, and may play a role in proton extrusion in order to achieve transepithelial HCO3(-) secretion. In apical cell membrane may be involved in mediating sodium absorption. Requires for normal levels of gastric acid secretion, secretory membrane development, parietal cell maturation and/or differentiation and at least secondarily for chief cell differentiation (By similarity).. | |
Protein Sequence | MALQMFVTYSPWNCLLLLVALECSEASSDLNESANSTAQYASNAWFAAASSEPEEGISVFELDYDYVQIPYEVTLWILLASLAKIGFHLYHRLPGLMPESCLLILVGALVGGIIFGTDHKSPPVMDSSIYFLYLLPPIVLEGGYFMPTRPFFENIGSILWWAVLGALINALGIGLSLYLICQVKAFGLGDVNLLQNLLFGSLISAVDPVAVLAVFEEARVNEQLYMMIFGEALLNDGITVVLYNMLIAFTKMHKFEDIETVDILAGCARFIVVGLGGVLFGIVFGFISAFITRFTQNISAIEPLIVFMFSYLSYLAAETLYLSGILAITACAVTMKKYVEENVSQTSYTTIKYFMKMLSSVSETLIFIFMGVSTVGKNHEWNWAFICFTLAFCQIWRAISVFALFYISNQFRTFPFSIKDQCIIFYSGVRGAGSFSLAFLLPLSLFPRKKMFVTATLVVIYFTVFIQGITVGPLVRYLDVKKTNKKESINEELHIRLMDHLKAGIEDVCGHWSHYQVRDKFKKFDHRYLRKILIRKNLPKSSIVSLYKKLEMKQAIEMVETGILSSTAFSIPHQAQRIQGIKRLSPEDVESIRDILTSNMYQVRQRTLSYNKYNLKPQTSEKQAKEILIRRQNTLRESMRKGHSLPWGKPAGTKNIRYLSYPYGNPQSAGRDTRAAGFSDDDSSDPGSPSITFSACSRIGSLQKQEAQEIIPMKSLHRGRKAFSFGYQRNTSQEEYLGGVRRVALRPKPLFHAVDEEGESGGESEGKASLVEVRSRWTADHGHGRDHHRSHSPLLQKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
342 | N-linked_Glycosylation | MKKYVEENVSQTSYT HHHHHHHCCCCCCHH | 25.82 | UniProtKB CARBOHYD | |
352 | Ubiquitination | QTSYTTIKYFMKMLS CCCHHHHHHHHHHHH | 30.28 | 22817900 | |
356 | Ubiquitination | TTIKYFMKMLSSVSE HHHHHHHHHHHCCCH | 27.13 | 22817900 | |
463 | Phosphorylation | TLVVIYFTVFIQGIT HHHHHHHHHHHCCCC | 9.49 | - | |
541 | Phosphorylation | IRKNLPKSSIVSLYK HHCCCCHHHHHHHHH | 24.29 | 23312004 | |
542 | Phosphorylation | RKNLPKSSIVSLYKK HCCCCHHHHHHHHHH | 32.89 | 23312004 | |
613 | Phosphorylation | RTLSYNKYNLKPQTS HHHHCCCCCCCCCCC | 23.30 | 21712546 | |
619 | Phosphorylation | KYNLKPQTSEKQAKE CCCCCCCCCHHHHHH | 47.59 | 21712546 | |
634 | Phosphorylation | ILIRRQNTLRESMRK HHHHHHHHHHHHHHC | 20.89 | - | |
638 | Phosphorylation | RQNTLRESMRKGHSL HHHHHHHHHHCCCCC | 19.90 | 22468782 | |
644 | Phosphorylation | ESMRKGHSLPWGKPA HHHHCCCCCCCCCCC | 44.81 | - | |
660 | Phosphorylation | TKNIRYLSYPYGNPQ CCEEEEEECCCCCCC | 18.35 | 28857561 | |
673 | Phosphorylation | PQSAGRDTRAAGFSD CCCCCCCCCCCCCCC | 22.35 | - | |
688 | Phosphorylation | DDSSDPGSPSITFSA CCCCCCCCCCEEHHH | 22.36 | 22210691 | |
701 | Phosphorylation | SACSRIGSLQKQEAQ HHHHHCCCCCHHHHH | 25.84 | 22210691 | |
724 | Phosphorylation | HRGRKAFSFGYQRNT CCCCCHHHCCCCCCC | 23.71 | - | |
732 | Phosphorylation | FGYQRNTSQEEYLGG CCCCCCCCHHHHCCC | 38.86 | 26657352 | |
792 | Phosphorylation | RDHHRSHSPLLQKK- CCCCCCCCHHHCCC- | 20.63 | 26657352 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SL9A4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SL9A4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SL9A4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of SL9A4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Ubiquitylation | |
Reference | PubMed |
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry."; Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.; Proteomics 7:868-874(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-352, AND MASSSPECTROMETRY. |